Display options
Share it on

Surg Case Rep. 2017 Dec;3(1):46. doi: 10.1186/s40792-017-0322-2. Epub 2017 Mar 20.

Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report.

Surgical case reports

Shinkichi Takamori, Masafumi Yamaguchi, Kenichi Taguchi, Makoto Edagawa, Shinichiro Shimamatsu, Ryo Toyozawa, Kaname Nosaki, Fumihiko Hirai, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose

Affiliations

  1. Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.
  2. Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan. [email protected].

PMID: 28321808 PMCID: PMC5359261 DOI: 10.1186/s40792-017-0322-2

Abstract

Some features found on chest computed tomography (CT), such as central tumor location, large pleural effusion, and the absence of a pleural tail, and a patient age of less than 60 years, have been suggested to be useful in predicting anaplastic lymphoma kinase (ALK) rearrangement in patients with non-small cell lung cancer (NSCLC).A 68-year-old female patient with a history of gynecological treatment was found to have a cavitary mass in the right lower lobe on an annual chest roentgenogram. The tumor was located in the peripheral area with a pleural tail showing no pleural effusion. In addition, two pure ground-glass-opacity nodules (p-GGNs) in the right upper lobe of the lung were detected on consecutive chest CT scans. The patient underwent right lower lobectomy, partial resection of the right upper lobe, and hilar mediastinal lymph node dissection for complete resection of each tumor. The pathological diagnosis was invasive mucinous adenocarcinoma with signet-ring cells for the cavitary mass in the right lower lobe and invasive adenocarcinoma for the rest of the p-GGNs; subcarinal lymph node metastasis was also detected. The ALK rearrangement was detected by fluorescence in situ hybridization from the cavitary mass. The patient underwent four cycles of cisplatin and vinorelbine chemotherapy as standard adjuvant chemotherapy for pStage III NSCLC. The ALK fusion gene status of NSCLC with atypical CT features should also be investigated.

Keywords: Anaplastic lymphoma kinase; Cavitary mass; Radiological feature

References

  1. Ann Thorac Surg. 2016 Feb;101(2):473-80 - PubMed
  2. Radiology. 2015 Apr;275(1):272-9 - PubMed
  3. Eur Radiol. 2016 Jan;26(1):32-42 - PubMed
  4. Clin Cancer Res. 2009 Aug 15;15(16):5216-23 - PubMed
  5. Diagn Cytopathol. 2016 Jul;44(7):607-11 - PubMed
  6. Lung Cancer. 2014 Nov;86(2):190-4 - PubMed
  7. Radiology. 2014 Aug;272(2):568-76 - PubMed
  8. J Thorac Oncol. 2016 Jun;11(6):819-26 - PubMed

Publication Types